Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people living with central nervous system (CNS) conditions. The Company's commercial products include Auvelity, Sunosi and Symbravo. It is also advancing a diversified, late-stage pipeline of product candidates for serious neurological and psychiatric conditions, which include AXS-05, AXS-12, AXS-14 and AXS-17. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of major depressive disorder (MDD). Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. Symbravo (meloxicam and rizatriptan, 20 mg/10mg tablets) is an oral, single-dose medicine approved for the acute treatment of migraine with or without aura in adults.
What is the share price of Axsome Therapeutics, Inc. today?
Axsome Therapeutics, Inc. (AXSM) share price as of March 20, 2026 is $158.88. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Axsome Therapeutics, Inc.?
Yes, Indian Investors can invest in the Axsome Therapeutics, Inc. (AXSM) Share by opening an international trading account with Angel One.
How can I purchase Axsome Therapeutics, Inc. shares in India?
Purchasing Axsome Therapeutics, Inc. (AXSM) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Axsome Therapeutics, Inc. (AXSM) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Axsome Therapeutics, Inc.?
Yes, you can purchase fractional shares of Axsome Therapeutics, Inc. (AXSM) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Axsome Therapeutics, Inc.?
The market capitalization of Axsome Therapeutics, Inc. on February 11, 2026, is $8.13 B.
In which sector Axsome Therapeutics, Inc. belongs?
Axsome Therapeutics, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.
What documents are required to invest in Axsome Therapeutics, Inc. stocks?
In order to invest in Axsome Therapeutics, Inc. (AXSM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
